ArticleThe international journal of cardiovascular imaging2025
Coronary microvascular dysfunction in gestational diabetes: insights on possible mechanism from a large institutional registry.
Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes is associated with an increased risk of coronary artery disease (CAD) and adverse cardiovascular events in later life. Coronary microvascular dysfunction is a common precursor of CAD. Although microvascular dysfunction is common in gestational diabetes (GDM), the exact mechanisms remain unknown. We aimed to study the associations between coronary flow reserve (CFR) with common biomarkers of hyperglycemia, insulin resistance, inflammation and oxidative stress. Measurement of CFR was performed noninvasively using echocardiography in all patients. Patients with a low CFR (≤ 2.5) had higher HbA1c%, HOMA-IR, triglyceride-glucose index, uric acid, and total and non-HDL cholesterol as compared to those with a normal CFR (> 2.5). On univariate analysis, there was strong evidence favoring an association between CFR with HbA1c% (r=-0.32, p < 0.001, BF
Indexed as
Identifiers
41129088What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.